Annual Cash & Cash Equivalents
$635.37 M
+$258.83 M+68.74%
March 31, 2024
Summary
- As of February 12, 2025, IMVT annual cash & cash equivalents is $635.37 million, with the most recent change of +$258.83 million (+68.74%) on March 31, 2024.
- During the last 3 years, IMVT annual cash & cash equivalents has risen by +$235.22 million (+58.78%).
- IMVT annual cash & cash equivalents is now at all-time high.
Performance
IMVT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$374.69 M
-$98.26 M-20.78%
December 31, 2024
Summary
- As of February 12, 2025, IMVT quarterly cash and cash equivalents is $374.69 million, with the most recent change of -$98.26 million (-20.78%) on December 31, 2024.
- Over the past year, IMVT quarterly cash and cash equivalents has dropped by -$316.25 million (-45.77%).
- IMVT quarterly cash and cash equivalents is now -45.77% below its all-time high of $690.94 million, reached on December 31, 2023.
Performance
IMVT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IMVT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +68.7% | -45.8% |
| 3 y3 years | +58.8% | -28.9% |
| 5 y5 years | +531.8% | +203.3% |
IMVT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +68.7% | -45.8% | +38.8% |
| 5 y | 5-year | at high | >+9999.0% | -45.8% | +272.6% |
| alltime | all time | at high | >+9999.0% | -45.8% | >+9999.0% |
Immunovant Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $374.69 M(-20.8%) |
| Sep 2024 | - | $472.94 M(-15.5%) |
| Jun 2024 | - | $560.00 M(-11.9%) |
| Mar 2024 | $635.37 M(+68.7%) | $635.37 M(-8.0%) |
| Dec 2023 | - | $690.94 M(+156.0%) |
| Sep 2023 | - | $269.93 M(-18.2%) |
| Jun 2023 | - | $329.96 M(-12.4%) |
| Mar 2023 | $376.53 M(-23.8%) | $376.53 M(-13.0%) |
| Dec 2022 | - | $432.61 M(+6.6%) |
| Sep 2022 | - | $405.77 M(-5.0%) |
| Jun 2022 | - | $427.20 M(-13.5%) |
| Mar 2022 | $493.82 M | $493.82 M(-6.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | - | $527.00 M(-5.7%) |
| Sep 2021 | - | $558.95 M(+47.5%) |
| Jun 2021 | - | $379.00 M(-5.3%) |
| Mar 2021 | $400.15 M(+297.9%) | $400.15 M(-5.2%) |
| Dec 2020 | - | $421.97 M(-5.0%) |
| Sep 2020 | - | $444.37 M(+58.5%) |
| Jun 2020 | - | $280.28 M(+178.7%) |
| Mar 2020 | $100.57 M(>+9900.0%) | $100.57 M(-18.6%) |
| Dec 2019 | - | $123.53 M(+7571.2%) |
| Sep 2019 | - | $1.61 M(-15.8%) |
| Jun 2019 | - | $1.91 M(+1193.6%) |
| Mar 2019 | - | $147.80 K |
| Dec 2018 | $325.00 K | - |
FAQ
- What is Immunovant annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Immunovant?
- What is Immunovant annual cash & cash equivalents year-on-year change?
- What is Immunovant quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Immunovant?
- What is Immunovant quarterly cash and cash equivalents year-on-year change?
What is Immunovant annual cash & cash equivalents?
The current annual cash & cash equivalents of IMVT is $635.37 M
What is the all time high annual cash & cash equivalents for Immunovant?
Immunovant all-time high annual cash & cash equivalents is $635.37 M
What is Immunovant annual cash & cash equivalents year-on-year change?
Over the past year, IMVT annual cash & cash equivalents has changed by +$258.83 M (+68.74%)
What is Immunovant quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IMVT is $374.69 M
What is the all time high quarterly cash and cash equivalents for Immunovant?
Immunovant all-time high quarterly cash and cash equivalents is $690.94 M
What is Immunovant quarterly cash and cash equivalents year-on-year change?
Over the past year, IMVT quarterly cash and cash equivalents has changed by -$316.25 M (-45.77%)